[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Technology](https://github.com/mm80843/T3.5/tree/pages/docs/Technology/index.md) >> Individual ID:PBN__Technology_6602 

# __Biomedical research__

## Risks linked to this technology

* [Development of new drugs and antibodies may not cover all variations of the human coronavirus, leading to gaps in treatment options.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5415.md)
* [Limited understanding of the new disease covid-19](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_17453.md)

## This Technology belongs to this TechGroup

* [Healthcare](https://github.com/mm80843/T3.5/blob/pages/TechGroup/PBN__TechGroup_2.md)

## This Technology belongs to this TechSubgroup

* [Diagnostic testing](https://github.com/mm80843/T3.5/blob/pages/TechSubgroup/PBN__TechSubgroup_7.md)

## This technology is mentioned by

* [Bayoudhi_overview_2021](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_411.md)
* [Ning_impacts_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_631.md)

